Frontiers in Pharmacology (Aug 2022)

Role of ferroptosis and ferroptosis-related non-coding RNAs in the occurrence and development of gastric cancer

  • Ling Lu,
  • Bei Chen,
  • Bei Chen,
  • Yumeng Xu,
  • Xinyi Zhang,
  • Longtao Jin,
  • Hui Qian,
  • Yi Wang,
  • Zhao Feng Liang

DOI
https://doi.org/10.3389/fphar.2022.902302
Journal volume & issue
Vol. 13

Abstract

Read online

Gastric cancer (GC) is a malignant cancer of the digestive tract and is a life-threatening disease worldwide. Ferroptosis is a newly discovered form of regulated cell death, which involves the accumulation of iron-dependent lipid peroxides. It has been found that ferroptosis plays an important regulatory role in the occurrence, development, drug resistance, and prognosis of GC. Non-coding RNAs (ncRNAs) play a critical role in the occurrence and progression of a variety of diseases including GC. In recent years, the role of ferroptosis and ferroptosis-related ncRNAs (miRNA, lncRNA, and circRNA) in the occurrence, development, drug resistance, and prognosis of GC has attracted more and more attention. Herein, we briefly summarize the roles and functions of ferroptosis and ferroptosis-related ncRNAs in GC tumorigenesis, development, and prognosis. We also prospected the future research direction and challenges of ferroptosis and ferroptosis-related ncRNAs in GC.

Keywords